These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36786872)

  • 21. Biologic Therapies for Autoimmune and Connective Tissue Diseases.
    Wolfe RM; Ang DC
    Immunol Allergy Clin North Am; 2017 May; 37(2):283-299. PubMed ID: 28366477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Levels of satisfaction with rheumatoid arthritis treatment and associated alignment between physicians and patients across Latin America.
    Alves Pereira I; Maldonado Cocco J; Feijó Azevedo V; Guerra G; Bautista-Molano W; Casasola JC; Vega Morales D; Soriano ER; Gil DR; Zazzetti F; Aldunate L; Holdsworth EA; Massey O; Lobosco S; Lawson F
    Clin Rheumatol; 2020 Jun; 39(6):1813-1822. PubMed ID: 32030635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Nationwide Survey on Patient's versus Physician´s Evaluation of Biological Therapy in Rheumatoid Arthritis in Relation to Disease Activity and Route of Administration: The Be-Raise Study.
    De Mits S; Lenaerts J; Vander Cruyssen B; Mielants H; Westhovens R; Durez P; Elewaut D;
    PLoS One; 2016; 11(11):e0166607. PubMed ID: 27893771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of suffering from rheumatoid arthritis, systemic lupus erythematosus, and back pain on sexual functioning and marital satisfaction in Iran.
    Yazdi F; Shakibi MR; Gharavi Roudsari E; Nakhaee N; Salajegheh P
    Int J Rheum Dis; 2021 Mar; 24(3):373-379. PubMed ID: 33452762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes and sex differences in patient reported outcomes in rheumatoid factor positive RA-results from a community based study.
    Hekmat K; Jacobsson LT; Nilsson JÅ; Lindroth Y; Turesson C
    BMC Musculoskelet Disord; 2014 Feb; 15():44. PubMed ID: 24552546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bulgarian rheumatology: science and practice in a cost-constrained environment.
    Georgiev T; Stoilov R
    Rheumatol Int; 2019 Mar; 39(3):417-429. PubMed ID: 30413925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient-reported Outcomes, Resource Use, and Social Participation of Patients with Rheumatoid Arthritis Treated with Biologics in Alberta: Experience of Indigenous and Non-indigenous Patients.
    Barnabe C; Crane L; White T; Hemmelgarn B; Kaplan GG; Martin L; Maksymowych WP
    J Rheumatol; 2018 Jun; 45(6):760-765. PubMed ID: 29449496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality of life and drug compliance: their interrelationship in rheumatic patients.
    Hromadkova L; Soukup T; Vlcek J
    J Eval Clin Pract; 2015 Oct; 21(5):919-24. PubMed ID: 26083391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reuma.pt contribution to the knowledge of immune-mediated systemic rheumatic diseases.
    Santos MJ; Canhão H; Mourão AF; Oliveira Ramos F; Ponte C; Duarte C; Barcelos A; Martins F; Melo Gomes JA
    Acta Reumatol Port; 2017; 42(3):232-239. PubMed ID: 28917219
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease-modifying anti-rheumatic drugs: a systematic review and network meta-analysis.
    Singh JA; Hossain A; Tanjong Ghogomu E; Kotb A; Christensen R; Mudano AS; Maxwell LJ; Shah NP; Tugwell P; Wells GA
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD012183. PubMed ID: 27175934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoimmune liver diseases in systemic rheumatic diseases.
    Wang CR; Tsai HW
    World J Gastroenterol; 2022 Jun; 28(23):2527-2545. PubMed ID: 35949355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
    Goodman SM; Springer B; Guyatt G; Abdel MP; Dasa V; George M; Gewurz-Singer O; Giles JT; Johnson B; Lee S; Mandl LA; Mont MA; Sculco P; Sporer S; Stryker L; Turgunbaev M; Brause B; Chen AF; Gililland J; Goodman M; Hurley-Rosenblatt A; Kirou K; Losina E; MacKenzie R; Michaud K; Mikuls T; Russell L; Sah A; Miller AS; Singh JA; Yates A
    Arthritis Rheumatol; 2017 Aug; 69(8):1538-1551. PubMed ID: 28620948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the safety and satisfaction of rheumatic patients with accelerated infliximab infusion.
    de Carvalho JF; Dos Santos MNP; de Oliveira JMV; Lanty Silva ANS; de Araujo RPC; Cardozo JB
    Adv Rheumatol; 2018 Aug; 58(1):22. PubMed ID: 30657070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of early treatment on physical function in daily management of rheumatoid arthritis: a 5-year longitudinal study of rheumatoid arthritis patients in the National Database of Rheumatic Diseases in Japan.
    Hirata A; Suenaga Y; Miyamura T; Matsui T; Tohma S; Suematsu E; Ohnaka K; Takayanagi R
    Int J Rheum Dis; 2018 Apr; 21(4):828-835. PubMed ID: 27126059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Satisfaction and Awareness of Systemic Psoriasis Treatments: A National Survey Comparing Biologic and Nonbiologic Users.
    Ighani A; Yu AM; Sandhu VK; Barankin B; Manolson MF
    J Cutan Med Surg; 2019; 23(2):148-156. PubMed ID: 30801221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biologics and risk of tuberculosis in autoimmune rheumatic diseases: A real-world clinical experience from India.
    Shobha V; Chandrashekara S; Rao V; Desai A; Jois R; Dharmanand BG; Kumar S; Kumar P; Dharmapalaiah C; Mahendranath KM; Prasad S; Daware MA; Singh Y; Karjigi U; Nagaraj S; Anupama KR
    Int J Rheum Dis; 2019 Feb; 22(2):280-287. PubMed ID: 30168281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term trends in rheumatology care : Achievements and deficits in 25 years of the German national rheumatology database.
    Albrecht K; Callhoff J; Zink A
    Z Rheumatol; 2019 Dec; 78(Suppl 2):65-72. PubMed ID: 31407089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Long-term trends in rheumatology care : Achievements and deficits in 25 years of the German national rheumatology database].
    Albrecht K; Callhoff J; Zink A
    Z Rheumatol; 2019 Oct; 78(8):703-712. PubMed ID: 31297603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biologics-induced autoimmune renal disorders in chronic inflammatory rheumatic diseases: systematic literature review and analysis of a monocentric cohort.
    Piga M; Chessa E; Ibba V; Mura V; Floris A; Cauli A; Mathieu A
    Autoimmun Rev; 2014 Aug; 13(8):873-9. PubMed ID: 24840285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proliferation signal inhibitors for the treatment of refractory autoimmune rheumatic diseases: a new therapeutic option.
    Yoon KH
    Ann N Y Acad Sci; 2009 Sep; 1173():752-6. PubMed ID: 19758225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.